1) Ikeda M, Shigenobu K, Fukuhara R, et al:Efficacy of fluvoxamine as a treatment for behavioral symptoms in FTLD patients. Dement Geriatr Cogn Disord 17:117-121, 2004
2) 河野和彦:Donepezilの臨床的評価 第1報.臨精薬理 3:1053-1060,2000
3) Lampl Y, Sadeh M, Lorberboym M:Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia. Ann Pharma 38:1967-1968, 2004
4) Lebert F, Stekke W, Hasenbroekx C, et al:Frontotemporal dementia:A randomized, controlled trial with trazodone. Dement Geriatr Cogn Disord 17:355-359, 2004
5) Mendez MF, Shapira JS, McMurtray A, et al:Preliminary findings:Behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 15:84-87, 2007
6) 品川俊一郎:塩酸ドネペジルによる精神症状・行動障害の悪化が疑われた前頭側頭型認知症の1例.精神医学 51:689-692,2009
7) Tanaka M, Namiki C, Thuy DH, et al:Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease. J Neurol Sci 225:135-141, 2004
8) The Lund and Manchester Groups:Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 57:416-418, 1994